How long should a patient with normal kidney function stop taking Eliquis (apixaban) before blepharoplasty?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 3, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Stopping Eliquis Before Blepharoplasty

For a patient with normal kidney function undergoing blepharoplasty, stop Eliquis (apixaban) 48 hours before the procedure.

Bleeding Risk Classification

Blepharoplasty is classified as a high bleeding risk procedure because:

  • It involves vascular tissue with limited ability to achieve complete hemostasis 1
  • Bleeding complications in the periorbital space can cause vision-threatening hematomas 2, 3
  • The procedure requires meticulous hemostasis in a confined anatomical space where even minor bleeding can have significant functional consequences 3

Specific Timing for Apixaban Discontinuation

For patients with normal renal function (CrCl ≥80 mL/min):

  • Stop apixaban at least 48 hours before blepharoplasty 1
  • This means skipping 4 doses (since apixaban is dosed twice daily) 1
  • The FDA label confirms discontinuation should occur "at least 48 hours prior to elective surgery or invasive procedures with a moderate or high risk of unacceptable or clinically significant bleeding" 4

For patients with impaired renal function:

  • CrCl 50-79 mL/min: Stop 48 hours before 1
  • CrCl 30-49 mL/min: Stop 48 hours before 1
  • CrCl 15-29 mL/min: Stop 48 hours before 1

The French guidelines recommend stopping all factor Xa inhibitors (including apixaban) 3 days before high hemorrhagic risk procedures when CrCl is >30 mL/min 1

Critical Management Points

Do NOT use bridging anticoagulation:

  • Bridging with LMWH or heparin is not recommended when stopping apixaban 1
  • Bridging increases bleeding risk without reducing thrombotic events 1

Timing of resumption:

  • Resume apixaban 48-72 hours after the procedure once adequate hemostasis is established 1
  • The FDA label states to restart "as soon as adequate hemostasis has been established" 4
  • For high bleeding risk procedures like blepharoplasty, waiting closer to 72 hours is prudent 1

Common Pitfalls to Avoid

  • Do not rely on standard coagulation tests: INR and aPTT are unreliable for monitoring apixaban levels 1
  • Do not use the 24-hour rule: The 24-hour discontinuation window is only appropriate for low bleeding risk procedures, not blepharoplasty 1, 4
  • Verify renal function: Always calculate creatinine clearance using the Cockcroft-Gault formula before determining timing 1
  • Check for drug interactions: Patients taking concomitant P-glycoprotein inhibitors (dronedarone, amiodarone, verapamil) may need an additional 24 hours of interruption 1

Algorithm Summary

  1. Confirm normal renal function (CrCl ≥80 mL/min) 1
  2. Stop apixaban 48 hours before surgery (skip 4 doses) 1, 4
  3. No bridging anticoagulation 1
  4. Perform blepharoplasty with meticulous hemostasis 2, 3
  5. Resume apixaban 48-72 hours postoperatively once hemostasis is secure 1

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Complications of blepharoplasty: prevention and management.

Plastic surgery international, 2012

Related Questions

Is Eliquis (apixaban) 2.5 mg BID appropriate for a patient with polyarteritis, diabetes, COPD, and a partial traumatic amputation of the left foot with a painful tissue lesion?
Should a 56-year-old male heavy smoker with normal left ventricular size, normal wall thickness, and low-normal global systolic function continue taking Eliquis (apixaban)?
What is the cause of post-operative pain and hardening at the incision site in a 76-year-old male following thrombectomy for Pulmonary Embolism (PE) removal, currently on Eliquis (apixaban)?
What is the best course of action for a 94-year-old male with bilateral Deep Vein Thrombosis (DVT) of the lower extremities, currently on Eliquis (apixaban) 5 mg twice a day, with stable clots on ultrasound?
Are there concerns with starting Eliquis (apixaban) after Endoscopic Retrograde Cholangiopancreatography (ERCP)?
What is the appropriate dosage and administration of Caverjet (alprostadil) for an adult male with erectile dysfunction?
Does low-dose (81-100 mg/day) aspirin (acetylsalicylic acid) worsen endothelial function in adults with a history of cardiovascular disease or risk factors such as hypertension, diabetes, or hyperlipidemia?
What is the best course of treatment for a patient suspected of having a thyroid storm, particularly in the context of thyrotoxic periodic paralysis?
What is the management approach for a patient with atrial fibrillation (AF) who has reverted to sinus rhythm, with no significant underlying heart disease or comorbidities, and is at risk for stroke?
What is the best management approach for a 39-year-old female patient with a history of migraines, back pain, and depression, who presented with chest pain, mildly elevated troponins, and no significant evidence of coronary artery disease (CAD) on cardiac catheterization, but possible coronary artery spasm or microvascular angina?
What antibiotic can be used to treat a furuncle in a patient with a known allergy to amoxicillin and sulfa (sulfonamides)?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.